Stepan Co stock
SCLNYSEBasic MaterialsISIN US8585861003
51Score 51 out of 100, Neutral
Price and trend
81 / 100
Price history
+52% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 15% above it.
Since May 2026 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 57).
The price is 6.1% below its 52-week high. Largest decline in 20 years: 69% (May 2021 to November 2025).
Chart figures for advanced users
- SMA 50$63.99
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$57.51
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)57
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$42.38
- The lowest closing price of the last twelve months.
- Resistance$70.65
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Stepan Co belongs to the Chemicals (Specialty) industry (United States) and, with a market value of $1.51B, is number 88 of 108 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $2.33B (up 7% year on year) and earnings of $46.9M (down 6.9%).
- MEQIRI Score 51 out of 100 (Neutral): rank 318 of 467 in Basic Materials, median 58.
Show more
- Our model puts fair value at $31.78, with the price 107% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Reliable dividendNo dividend cut for over 41 years.Capital allocation 51
- Consistently profitableProfit in all 10 fiscal years from 2016 to 2025.Fundamentals 65
Weaknesses
- Above fair valuePrice 107% above the fair value of $31.78.Valuation 28
- Margin fallingOperating margin 3%, average of the prior years 7.3% (to 2024).Profitability 20
- Negative free cash flowFree cash flow −$65.87M over the last 12 months.Fundamentals 65
Its standout strengths are momentum and technical analysis, while growth and profitability hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 52 to 51.
The fundamentals are in the middle range.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among smaller stocks.
From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- cyclical sector (energy or materials), as a group, crashed more often in the backtest
What lowers it
- stable momentum
- low growth grade (crashed less often in the backtest)
Valuation
Valuation signal
Significantly overvaluedClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $24.45 and expensive above $45.40 (uncertainty medium, based on the price swings of the past year).
Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $26.48, at 7.8% it would be $39.72.
Valuation metrics
From the dividend model alone; the profit includes one-off items, so there is no industry value.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 10% on the twelve months before. Revenue has grown solidly since 2006, at about 4% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 12%, operating 3%, net 2%.
Debt & balance sheet
latest quarterModerate debt, and interest is adequately covered.
Earnings
- Next earnings
- 22 Feb 2027in 102 days
- Last reported
- 28 Oct 2026EPS reported $0.94 (expected $0.73)above expectations
Analyst estimates
- Earnings per share
- $2.78+3.3%
- Revenue
- $2.58B+1.9%
- Earnings per share
- $3.72+0.8%
- Revenue
- $2.73B+1.9%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook mixed
Share price after the results: +7.3%Stepan confirms its 2026 goal of adjusted EBITDA growth, positive free cash flow and continued deleveraging, but warns of lower volume growth in Q4 after 6% and 7% growth in prior quarters.
“When you think about 6% volume, in Q2 and 7% volume in Q3, we are expecting a lower growth in Q4 for sure.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 28 Oct 2026 (fiscal Q3 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
No open-market purchases or sales in the last 6 months.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Stepan Co
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
467 rated companies in Basic Materials
- This company
- 51
- Sector median
- 58
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- InnospecIOSP $1.93B64
- VERBIO Vereinigte BioEnergieVBK.DE $1.86B53
- CorbionCRBN.AS $1.71B66
- BorregaardBRG.OL $1.65B63
- Industrie De NoraDNR.MI $1.29B44
- ElkemELK.OL $1.24B51
- EcovystECVT $1.18B48
- Oil-Dri Corporation of AmericaODC $985.66M74
ETFs that hold Stepan Co
Held by 11 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Avantis Global Small Cap Value UCITS ETFAVWS | 0.14% | 0.39% | €1.47B |
| iShares S&P SmallCap 600 UCITS ETFIUS3 | 0.08% | 0.30% | €2.28B |
| L&G Russell 2000 US Small Cap Quality UCITS ETFETLZ | 0.05% | 0.30% | €185.82M |
Show 5 more
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)ZPRR | 0.05% | 0.30% | €4.22B |
| Xtrackers Russell 2000 UCITS ETF 1CXRS2 | 0.05% | 0.30% | €2.17B |
| State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETFZPRV | 0.05% | 0.30% | €944.34M |
| iShares MSCI World Small Cap UCITS ETFIUSN | 0.01% | 0.35% | €8.19B |
| iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETFSXRG | 0.01% | 0.43% | €2.48B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 29 Oct 2026)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.